Aesica Appoints Commercial Managing Director - - BioPharm International

ADVERTISEMENT

Aesica Appoints Commercial Managing Director



Aesica, a CDMO, has appointed Ian Muir to the newly created position of commercial managing director, effective on February 24. Muir’s responsibilities will cross all three of the company’s service offerings in API manufacturing, formulation development, and formulated products. He will also lead the expansion of the business into new markets, including China and Japan. Muir will report directly to Robert Hardy, CEO, and will be joining the Aesica Board.

Previously, Muir worked at Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms. He also has commercial experience in contract manufacturing roles for pharmaceutical companies located in Europe, the US, and Australia.

Source: Aesica
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines

Click here